Rontis

What Rontis does

Rontis is a privately held Swiss-domiciled multinational healthcare corporation that manufactures and distributes specialty generic pharmaceuticals, over-the-counter products, and specialty pharmaceutical formulations alongside interventional cardiology, interventional radiology, and nephrology medical devices. Its product portfolio spans quality generics, modified/sustained-release formulations, drug-eluting and bare-metal stents, balloon catheters (Cronus, Europa, InRo, Triton families), the Zeus CC peripheral stent system, and extracorporeal bloodline circuits for dialysis, supported by an in-house R&D laboratory and proprietary drug-delivery platforms including the patented CLEVER drug release system and the in-development BioCoStent next-generation drug-eluting stent. Manufacturing is anchored by a 17,800m² EU GMP-approved pharmaceutical and medical device plant in Larissa, Greece and a medical device facility in Veles, North Macedonia, with ISO 13485/ISO 9001 certification and TÜV Nord CERT Class III approval under EU MDR 2017/745.

The company operates a four-stream revenue model: proprietary pharmaceutical and medical device product sales via direct enterprise field sales across 65+ countries, contract manufacturing (CMO) services for multinational pharmaceutical companies at its EU GMP facilities, licensing of CTD dossiers and marketing authorizations globally, and exclusive regional distribution of third-party medical device portfolios (Stryker in Greece & Cyprus for 35+ years, TerumoBCT in Greece since 2012). End customers are hospitals, clinics, pharmacies, and university hospital research partners; distribution partners and CMO clients represent key B2B counterparties. R&D is partly funded through EU and Greek national grants, with active academic collaborations across Greek universities and research foundations.

Name

Rontis

Legal name

Rontis Corporation

Website

https://rontis.com

Company type

Private

Founded year

1933

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Rontis is a privately held Swiss-headquartered healthcare corporation that manufactures specialty generic pharmaceuticals and interventional cardiology/radiology/nephrology medical devices in Greece and North Macedonia, distributing through direct sales in 65+ countries and exclusive partnerships with Stryker and TerumoBCT.

Ownership category

akta.pro rank

Product category

Pharmaceutical & Medical Device Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Surgical and Medical Instrument Manufacturing (339112), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

Keywords

• Generic pharmaceuticals manufacturing
• Interventional cardiology devices
• Medical device manufacturing
• Contract pharmaceutical manufacturing
• Drug-eluting stents

Headquarters

HQ city

Zug

HQ country

Switzerland

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Development, production and distribution of high-quality specialty generic medicines, OTC products, and specialty pharmaceutical products including modified/sustained release tablets and capsules
2. Medical Devices Product Sales: Research, development, manufacture and distribution of state-of-the-art specialty medical devices for Interventional Cardiology, Interventional Radiology, Nephrology and Liquid Administration including drug-eluting/bare metal stents, balloons, guide wires, and extracorporeal bloodline circuits
3. Contract Manufacturing (CMO): Providing high-quality outsourced production services for multinational pharmaceutical companies' finished products at EU GMP approved facilities
4. Licensing Activities: Marketing authorizations issued globally for pharmaceutical portfolio; licensing arrangements for CTD dossiers to partners

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Rontis manufactures and distributes specialty generic pharmaceuticals, OTC products, and advanced medical devices for interventional cardiology, interventional radiology, and nephrology. The company operates EU GMP-certified production facilities and supplements its own-product portfolio with contract manufacturing services for multinational pharmaceutical companies and exclusive distribution of third-party medical technology brands such as Stryker and TerumoBCT in Greece and Cyprus.

Product overview

Rontis is a multinational healthcare corporation offering a dual product portfolio: Pharmaceuticals (Quality Generics, OTC, and Specialty Pharmaceutical Products) and Medical Devices (Interventional Cardiology/Radiology products and Nephrology products). The pharmaceutical division focuses on generic medicines and specialty formulations, while the medical devices division researches, develops, manufactures, and distributes interventional products including balloon catheters (Cronus, Europa, InRo, Triton families), stents (Zeus CC), and nephrology bloodline circuits. The company also serves as an exclusive distributor for Stryker and TerumoBCT branded products in Greece and Cyprus, and maintains active R&D programs including BioCoStent (drug-eluting stents), Clever Balloon (drug-coated balloons), and Multivort (generic cariprazine development).

Differentiator

Problem solved

Functional benefit

Brands

• Cronus: Peripheral balloon catheter product line including Cronus Advanced, Cronus HP (High Pressure), Cronus NV (Non-Vascular), and Cronus UP (Ultra Pressure)
• Zeus
• Europa Ultra
• InRo
• Triton
• Biocostent
• Clever Balloon
• Multivort

Products and services

• Quality Generics A portfolio of specialty generic pharmaceutical products developed and manufactured in-house by Rontis for distribution to pharmaceutical companies, healthcare providers, and patients across 65+ countries.
• OTC Products Over-the-counter consumer health products manufactured by Rontis and sold through pharmacy and retail channels in the company's international markets.
• Specialty Pharmaceutical Products Specialty pharmaceutical products targeting defined therapeutic areas, developed and manufactured by Rontis for global distribution.
• CTD Dossiers Regulatory Common Technical Document (CTD) dossier preparation and submission services provided to support marketing authorizations for pharmaceutical products across international markets.
• Interventional Cardiology Products Interventional cardiology devices developed and manufactured by Rontis, including balloon catheters and stent systems used by interventional cardiologists to treat cardiovascular disease.
• Interventional Radiology Products Interventional radiology devices developed and manufactured by Rontis, including peripheral balloon catheters used in vascular and other image-guided procedures.
• Nephrology Products Nephrology medical devices developed and manufactured by Rontis for the treatment of renal conditions and for dialysis-related clinical use.
• BioCoStent Proprietary drug-eluting stent technology developed by Rontis as part of its interventional cardiology portfolio, leveraging the company's drug-delivery IP.
• Clever Balloon Proprietary drug-coated balloon catheter developed by Rontis, based on the company's CLEVER Drug Release System, for interventional cardiology applications.
• Multivort Interventional medical device product in Rontis' research and development pipeline intended for use in interventional procedures.
• Contract Manufacturing (CMO) Services Contract manufacturing organization (CMO) services provided by Rontis to multinational pharmaceutical companies, leveraging EU GMP-certified facilities, regulatory dossier expertise, and large-scale production capacity for generics, OTC, and specialty pharmaceutical products.
• Stryker Medical Technology Distribution Exclusive distribution of Stryker medical technology products in Greece and Cyprus, supplying hospitals and healthcare providers with Stryker's medical devices through Rontis as the authorized local distributor.
• TerumoBCT Medical Technology Distribution Exclusive distribution of TerumoBCT medical technology products in Greece and Cyprus, supplying hospitals, blood banks, and cell therapy centers with TerumoBCT's portfolio through Rontis as the authorized local distributor.

Quantifiable outcome

• Top 15% of all companies assessed by EcoVadis (2025)
• +4 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered core, major and minor.

• StrykercoreChannel Partner/ Reseller/ Distributor35+ year exclusive distribution partnership (since 1988); Rontis Hellas SA distributes full Stryker product portfolio in Greece & Cyprus including Arthroplasty, Osteosynthesis, Sports Medicine, Spine, Interventional Pain, OR Capital Equipment, Medical Acute Care, Neurovascular products, and Mako Robotic assisted technology acquired by Stryker in 2016
• TerumoBCTcoreChannel Partner/ Reseller/ DistributorExclusive distribution partnership since 2012; focused Haemapheresis, Bloodbank and Transfusion Business Unit promotes TerumoBCT technology in Greece; provides solutions for blood processing, component collection, and cell therapy
• University of ThessalymajorStrategic or Co-development PartnerAcademic research partner in BioCoStent project (novel drug-coated coronary stents) as coordinator; also partner in Clever Balloon project; involved in cariprazine development research
• University of IoanninamajorStrategic or Co-development PartnerResearch partner in BioCoStent and Clever Balloon projects; contributing to development of novel drug-eluting stents and drug-coated balloon catheters
• University of PatrasmajorStrategic or Co-development PartnerResearch partner in Clever Balloon project with Department of Chemistry; collaboration on cariprazine generic development through Associate Professor Dr. G. Rassias research group
• Biomedical Research Foundation of the Academy of AthensmajorStrategic or Co-development PartnerResearch partner in BioCoStent and Clever Balloon projects contributing to novel drug-coated coronary implants and endovascular drug-coated balloon development
• FEAC EngineeringminorStrategic or Co-development PartnerCollaborative partner in BioCoStent project focusing on novel drug-coated coronary implantable stents development

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Biotronik: German cardiovascular medical device manufacturer specializing in interventional cardiology and radiology products including stents, balloon catheters, and pacemakers. Incumbent peer in same end-markets as Rontis's interventional cardiology product family, but with established global sales infrastructure and broader product portfolio.

Direct peers

• B. Braun: German integrated manufacturer of pharmaceuticals and medical devices including IV therapy, interventional cardiology, surgical instruments, and clinical nutrition. Most directly comparable peer given Rontis's similar combination of pharma manufacturing, medical device production (Cronus, Zeus, Europa, InRo, Triton), and global distribution footprint.
• Fresenius Kabi: Global medical devices and pharmaceuticals company focused on IV therapy, clinical nutrition, and injectable drugs. Comparable on combination medical device + pharma business model, EU-headquartered manufacturing, and product offerings for hospitals and clinics.
• Elpen Pharmaceutical: Greek pharmaceutical manufacturer with branded generics, specialty pharma, and medical devices. Domestic geographic peer serving similar Greek and regional markets with comparable regulatory positioning and product categories.
• Hikma Pharmaceuticals: MENA-headquartered multinational pharma company with generics, injectables, and specialty pharma segments plus licensing/dossier monetization. Directly comparable on specialty generics portfolio, licensing of CTD dossiers, CMO arrangements, and multi-region commercial reach.
• Krka: Slovenian pharmaceutical manufacturer with similar mid-cap scale, specialty generics + branded pharma portfolio, and European + emerging markets commercial reach. Highly comparable on business model (generics + specialty formulations), manufacturing scale, and regional go-to-market strategy.
• Alkaloid: North Macedonia-headquartered pharma manufacturer with similar Balkan regional positioning. Geographic peer sharing North Macedonian manufacturing footprint and competitive overlap in European generic pharma markets.
• Stada Arzneimittel: European specialty and generic pharma company with integrated CMO capabilities and similar mid-cap scale. Directly comparable on specialty generics + value-added formulations strategy, EU GMP manufacturing footprint, and focus on post-patent-cliff molecules.

Others

• Aenova Group: European pharmaceutical CDMO providing contract manufacturing services for drug products. Comparable as CDMO peer to Rontis's CMO services for multinational pharma companies, though focused exclusively on contract manufacturing rather than integrated branded product development.

Emerging players

• Meril Life Sciences: Indian medical device company developing drug-eluting stents, drug-coated balloons, and other interventional cardiology products. Direct technology peer to Rontis's BioCoStent and CLEVER Balloon programs in cardiovascular intervention. Emerging challenger against incumbent DES/DCB manufacturers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights8 records

Customer concentration

• Xx.com/RontisC

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rontis